event tracking

International Linked Clinical Trials (iLCT)

25 results.

January 29, 2019 Australian Government invests in innovative genomic testing in Linked Clinical Trials program

This story originally appeared on The Cure Parkinson’s Trust website. To learn more, click here.   It was announced today that the Australian Parkinson's…

October 10, 2018 ICYMI: Three big takeaways from Grand Challenges in Parkinson’s Disease

Did you miss Grand Challenges in Parkinson’s Disease and Rallying to the Challenge? Don’t worry. We have you covered. Just over a week ago, the…

June 13, 2018 From discovery to medicine
Part three: What we’re doing to move lab discoveries into the clinic

In the past few weeks, VAI Voice has discussed what it takes to translate a promising laboratory discovery into a life-changing, approved treatment. In our…

June 7, 2018 From discovery to medicine
Part two: Before a new medication can be used in patients, it must go through a gauntlet of tests to ensure it is safe and effective

In the second installment in our multi-part series on how a new medication moves from the lab to the doctor’s office, we take a look…

August 2, 2017 Promising results from study of type 2 diabetes drug in treatment of Parkinson’s disease

Evidence continues to mount that a newer class of anti-diabetic drugs called incretin mimetics, or glucagon-like peptide-1 receptor agonists, could slow…

VAI DEFAULT HEADER
September 7, 2016 Diabetes drug focus of new clinical trial for Parkinson’s disease

HIGHLIGHTS A clinical trial is now underway at Cedars-Sinai in Los Angeles to test the efficacy and safety of a type II diabetes drug as…

VAI DEFAULT HEADER
July 11, 2016 Michael J. Fox Foundation, Van Andel Research Institute and The Cure Parkinson’s Trust collaborate to assess the clinical use and development of nilotinib in Parkinson’s disease

Note: To read the commentary published in the Journal of Parkinson's Disease click here. Investigators will focus on safety for long-term use in non-cancer…

VAI DEFAULT HEADER
February 21, 2016 Promising respiratory drug focus of new clinical trial for Parkinson’s disease

GRAND RAPIDS, Mich. (February 22, 2016)—A medication approved to treat various respiratory diseases and that has demonstrated neuroprotective effects in preclinical studies is the focus…